High-purity SR17018 compound � mu-opioid receptor agonist for lab research

SR17018 (C007B-272173)

Catalog No.: C007B-272173
Mfr. No.: S412194-100mg
Mfr. Name: Aladdin Scientific
Qty/UOM: 1
UOM: EA

Price: $656.64

List Price: $729.59

InformationSR17018 is an agonist of mu-opioid-receptor (MOR) binding with GTPγS with EC50 of 97 nM.

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

Synonyms C74028 | 5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one | AC-35518 | EX-A1860 | A16902 | BCP29030 | SR-17018; SR 17018 | 2134602-45-0 | CS-0040938 | 2H-Benzimidazol-2-one, 5,6-dichloro-1-(1-((4-chlorophenyl)methyl)-4-piper

Specifications & Purity ≥98%

Biochemical and Physiological Mechanisms SR17018 is an agonist of mu-opioid-receptor (MOR) binding with GTPγS with EC50 of 97 nM.

Storage Temp Store at -20°C

Shipped In Ice chest + Ice pads

Product Description

Information

SR17018 is an agonist of mu-opioid-receptor (MOR) binding with GTPγS with EC50 of 97 nM.

UPC:: 51373422
Condition:: New
Availability:: 2 weeks
Weight:: 1.06 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: S412194-100mg
CAS:: 2134602-45-0
Product Size:: 100mg

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."